CopenDapp Labs ApS

Pitch Deck & Resources

Investor materials for SponCite, the AI-native operating layer for clinical trial site selection.

Schedule a CallView Pitch Deck

Executive Summary

Read-only overview for investor diligence and first calls.

SponCite: AI-Native Clinical Trial Site Selection

Problem

Clinical trial sponsors waste 9-12 months finding 40-50 verified sites. The current process is still driven by Rolodex calls, spreadsheets, and manual qualification.

Solution

Transparent AI matching engine with Glass Box scoring, verified site profiles, and NDA-aware workflows.

Market

€2B+ annual spend, dominated by spreadsheets and legacy systems.

Ask

€200K pre-seed to launch MVP Q3 2026 with 5 pilot sponsors.

Milestones

€50K -> 5 pilot sponsors live
€100K -> 20+ sites verified
€200K -> revenue-ready product

Pitch Deck Preview

Interactive 12-slide investor deck for SponCite, illustrated with current prototype screens.

01 / Cover

SponCite

Prototype evidence

The OS for clinical trial site selection

Glass Box AI + verified site profiles + transparent scoring

Sponsor command center

SponCite sponsor dashboard with active trials, shortlist counts, and quick actions

A workflow-first operating layer for sponsors, from portfolio overview to action.

Slide 1 of 12

Team

Founder-led execution with product, design, and software support.

Vadim Fedulov

Founder/CEO

PhD Neuroscience, Novo Nordisk, Radiometer Medical.

Nikolas

Design & Marketing Lead

Product and brand design lead supporting positioning, UX, and market-facing assets.

Lukas

Product & Technical Lead

Software and game-development experience supporting prototype workflows and technical delivery.